Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for Diminished Ovarian Reserve in IVF
NCT07871825Phase 4Recruiting
- Sponsor
- Center for Human Reproduction
- Start
- Feb 2026
- Primary completion
- Feb 2030
- Countries
- 1
01
Overview
A Phase 4 trial of filgrastim in Diminished Ovarian Reserve (DOR), sponsored by Center for Human Reproduction. Started Feb 2026; status: recruiting.
02
Drugs
filgrastim
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07871825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07871825.